NeutroFlow: Leading European Medical Consortium Awarded €2.5 Million Grant from EIC Transition Programme to Advance Predictive Biomarker D
A European-led consortium comprising Heidelberg University Hospital (UKHD), the European Institute of Oncology (IEO), Virgen Macarena University Hospital, and OncoHost today announced that it has been awarded a Ꞓ2.5 million grant under the EIC Transition Programme of Horizon Europe.
The funding will drive the consortiums collaborative efforts to develop _NeutroFlow_—a novel, point-of-care diagnostic test designed to predict patient response to immune checkpoint inhibitors (ICIs) across five cancer indications:!-->…